findmyKOL
Clinical trialNCT00297596CompletedPhase 2Interventional

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

SponsorSCRI Development Innovations, LLCEnrollment25Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Graves-Gilbert Clinic

    Bowling Green, Kentucky, United States

  • Hematology Oncology Life Center

    Alexandria, Louisiana, United States

  • Baton Rouge General Medical Center

    Baton Rouge, Louisiana, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

  • Chattanooga Oncology and Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2006
Primary completion
31 Oct 2008
Completion
31 Oct 2010
Last update posted
28 Oct 2021
Registered enrollment
25
Registry id
NCT00297596

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.